tm
Seeing Is Believing
tm
Seeing Is Believing
CRVS is currently covered by 4 analysts with an average price target of $30.78. This is a potential upside of $9.44 (44.24%) from yesterday's end of day stock price of $21.34.
Corvus Pharmaceuticals's activity chart (see below) currently has 51 price targets and 47 ratings on display. The stock rating distribution of CRVS is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 89.07% with an average time for these price targets to be met of 632.11 days.
Highest price target for CRVS is $42, Lowest price target is $11, average price target is $26.67.
Most recent stock forecast was given by ROGER SONG from JEFFERIES on 22-Jan-2026. First documented stock forecast 05-Apr-2017.
Currently out of the existing stock ratings of CRVS, 10 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 01-Dec-2021
$42
$21.3 (102.90%)
$13
12 days ago
(22-Jan-2026)
2/3 (66.67%)
$33.95 (421.74%)
748
Buy Since 02-Jan-2025
$27
$6.3 (30.43%)
$27
12 days ago
(22-Jan-2026)
3/5 (60%)
$18.95 (235.40%)
355
Buy Since 22-Oct-2024
$11
$-9.7 (-46.86%)
8 months 14 days ago
(20-May-2025)
2/2 (100%)
$7.32 (198.91%)
191
Buy Since 07-Oct-2022
$21
$0.3 (1.45%)
$12
1 years 4 months 18 days ago
(16-Sep-2024)
4/4 (100%)
$15.22 (263.32%)
652
Buy Since 27-May-2021
$4
1 years 10 months 2 days ago
(01-Apr-2024)
4/4 (100%)
$2.36 (143.90%)
708
What is CRVS (Corvus Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on CRVS (Corvus Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on CRVS (Corvus Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on CRVS (Corvus Pharmaceuticals)?
Which analyst is the currently most bullish on CRVS (Corvus Pharmaceuticals)?
Which analyst is the currently most reserved on CRVS (Corvus Pharmaceuticals)?
